scholarly article | Q13442814 |
P356 | DOI | 10.1097/PGP.0B013E31824FE2AA |
P698 | PubMed publication ID | 23018216 |
P50 | author | Aaron Pollett | Q42604241 |
Anna Marie Mulligan | Q59659727 | ||
Blaise A Clarke | Q60683603 | ||
Ghassan Allo | Q83386101 | ||
P2093 | author name string | Paul Ryan | |
Cyril Blake Gilks | |||
Fang-I Lu | |||
Keiyan Sy | |||
Particia A Shaw | |||
P433 | issue | 6 | |
P921 | main subject | DNA mismatch repair | Q2984243 |
P304 | page(s) | 524-531 | |
P577 | publication date | 2012-11-01 | |
P1433 | published in | International Journal of Gynecological Pathology | Q15746551 |
P1476 | title | Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors | |
P478 | volume | 31 |
Q36155553 | ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas |
Q58129865 | Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis |
Q48233383 | Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma. |
Q36059087 | Do hereditary syndrome-related gynecologic cancers have any specific features? |
Q50076405 | Early stage mucinous ovarian cancer: A review |
Q42142654 | Expression of human DNA mismatch-repair protein, hMSH2, in patients with oral lichen planus |
Q35821477 | Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary |
Q43875498 | MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome |
Q38067436 | Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates |
Q40765757 | Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients. |
Q100454927 | Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome |
Q55285321 | Ovarian carcinoma histotype in Lynch syndrome. |
Q51065192 | Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. |
Q38185144 | Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing |
Q40073731 | Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas |
Q28083904 | The molecular background of mucinous carcinoma beyond MUC2 |
Q28536689 | Type-specific cell line models for type-specific ovarian cancer research |
Search more.